The receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL) secreted by osteoblasts induces hepatic insulin resistance by activating NF-κB signaling, and β-cell dysfunction via the p38 mitogen-activated protein kinase (MAPK) signaling pathway [11]. Here, TNFSF11 is linked to Insulin resistance.